Telormedix, a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases, announced the start of a Phase I/II clinical study of TMX-101 for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). TMX-101 is an immunotherapeutic compound and Telormedix has already recruited [...]
A new therapy mounts a double-barreled attack on leukemia, targeting not just the cancer cells but also the environment in which those cells live and grow, University of Florida researchers report. Source: General Cancer News Articles Provided by Cancer Compass
In order to conduct rigorous and robust clinical trials, the tests, or assays, used in those trials must meet optimum standards. To bring those assays and standards in line with 21st century technology, NCI’s Division of Cancer Treatment and Diagnosis has started a new program called the Clinical Assay Development Program (CADP) to facilitate development [...]
Lung Cancer Alliance (LCA), the only national non-profit dedicated to providing support and advocacy for those living with or at risk for lung cancer, announced the launching of the first open access website for CT scans and clinical data donated by patients, called Give a Scan, that will increase [...]
CytRx Corporation, a biopharmaceutical company specializing in oncology, announced that its drug candidate bafetinib (formerly known as INNO- 406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Source: General Cancer News Articles Provided by Cancer Compass
GTx, Inc. announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate. Source: General Cancer News Articles Provided by [...]
Celldex Therapeutics, Inc. announced that the first patient has been screened in a randomized Phase 2 study of the Company’s novel, first-in- class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. Source: General Cancer News Articles Provided by Cancer Compass
US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, received unanimous approval from its Data and Safety Monitoring Board (DSMB) to continue enrollment in its FDA-approved prospective clinical trial investigating the use of high intensity focused ultrasound [...]
Genetic Tests Help Women Get Cancer Care That Fits Them Perfectly, According to American Clinical Laboratory … WASHINGTON, May 7 /PRNewswire-USNewswire/ — Important progress is being made in women’s health through the use of genetic tests, particularly those that help women detect and treat cancer. Read more on PR Newswire via Yahoo! News
Millennium: The Takeda Oncology Company announced the publication of results from the 682-patient, randomized, international Phase III VISTA1 trial in the Journal of Clinical Oncology (JCO). The results continue to show an extension in the length of life for patients taking VELCADE, melphalan and prednisone (VcMP) in the front-line [...]